Company
Caribou Biosciences
We are a clinical-stage biopharmaceutical company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases.
Also known as Caribou Biosciences, Inc.
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Berkeley, CA, United States
- Legal name
- Caribou Biosciences, Inc.
- cariboubio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are a clinical-stage biopharmaceutical company focused on developing transformative genome-edited allogeneic cell therapies for devastating human diseases.
Funding snapshot
- Total raised
- $141MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $115M2021-03-02
Funding rounds
- Round, 2021
- $115M2021-03-02, SEC form D sold, 36 investors
- Round, 2016
- $14.5M2016-05-12, SEC form D sold, 11 investors
- Round, 2014
- $11.5M2014-09-11, SEC form D sold, 14 investors
Loading relationship preview